MG
HAE icon

Michael Gelband’s Haemonetics HAE Stock Holding History

Michael Gelband’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,750
Closed -$2.69M – 1767
2026
Q1 		$2.69M Sell
47,750
-48,568
-50% -$3.16M 0.02% 655
2025
Q4 		$7.72M Sell
96,318
-215,533
-69% -$14.5M 0.06% 326
2025
Q3 		$15.2M Buy
311,851
+185,336
+146% +$11.5M 0.16% 119
2025
Q2 		$9.44M Buy
126,515
+62,174
+97% +$4.12M 0.08% 244
2025
Q1 		$4.09M Buy
64,341
+49,898
+345% +$3.39M 0.04% 473
2024
Q4 		$1.13M Sell
14,443
-66,500
-82% -$5.34M 0.01% 910
2024
Q3 		$6.51M Buy
80,943
+51,667
+176% +$4.17M 0.04% 324
2024
Q2 		$2.42M Buy
+29,276
New +$2.58M 0.02% 712
2023
Q3 		– Sell
-10,423
Closed -$887K – 1868
2023
Q2 		$887K Sell
10,423
-39,809
-79% -$3.37M 0.01% 1148
2023
Q1 		$4.16M Buy
50,232
+12,332
+33% +$998K 0.03% 581
2022
Q4 		$2.98M Buy
+37,900
New +$3.05M 0.04% 502
2022
Q1 		– Sell
-5,726
Closed -$304K – 2368
2021
Q4 		$304K Buy
+5,726
New +$349K ﹤0.01% 1653
2021
Q2 		– Sell
-6,015
Closed -$668K – 2529
2021
Q1 		$668K Sell
6,015
-32,473
-84% -$4.02M 0.01% 1165
2020
Q4 		$4.57M Sell
38,488
-14,171
-27% -$1.53M 0.04% 276
2020
Q3 		$4.59M Buy
52,659
+14,258
+37% +$1.25M 0.09% 190
2020
Q2 		$3.44M Buy
+38,401
New +$3.88M 0.09% 253
2020
Q1 		– Sell
-33,437
Closed -$3.84M – 1299
2019
Q4 		$3.84M Buy
+33,437
New +$4.05M 0.07% 202

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's HAE Position: Q2 2026 in Review

Michael Gelband sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 47,750 shares — an estimated $2.69M sold.

Michael Gelband first reported a position in HAE in Q4 2019 and held it in 17 quarters. The position peaked at $15.2M in Q3 2025. 327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Michael Gelband reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 47,750 Haemonetics shares in Q2 2026, an estimated $2.69M.
  • Michael Gelband first reported a position in Haemonetics in Q4 2019 and held it in 17 quarters.
  • Michael Gelband's Haemonetics position peaked at $15.2M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.